Corrigendum to: Toxoplasmosis Outbreak Associated With Toxoplasma gondii-Contaminated Venison-High Attack Rate, Unusual Clinical Presentation, and Atypical Genotype

Affiliations

• ¹ Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
• ² Bureau of Communicable Diseases, Division of Public Health, Wisconsin Department of Health Services, Madison, Wisconsin, USA.
• ³ Center for Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
• ⁴ Center for Global Health, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
• ⁵ INSERM, Université de Limoges, UMR_S 1094, Tropical Neuroepidemiology, Limoges, France.
• ⁶ University Hospital, French National Reference Center for Toxoplasmosis and Biological Resource Center for Toxoplasma, Limoges, France.
• ⁷ Infectious Disease Specialists of Southeast Wisconsin, Brookfield, Wisconsin, USA.
• ⁸ Jackson County Health and Human Services , Black River Falls, Wisconsin, USA.
• ⁹ United States Department of Agriculture, Agricultural Research Service, Animal Parasitic Diseases Lab, Beltsville, Maryland, USA.
• ¹⁰ Service de Parasitologie Mycologie, Centre Hospitalier Universitaire de Nice, INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, Faculté de Médecine, Virulence microbienne et signalisation inflammatoire - Université de la Côte d'Azur, Nice, France.
• ¹¹ Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
• ¹² The Jack S. Remington Laboratory for Specialty Diagnostics, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto, California, USA.
• ¹³ Division of Infectious Diseases, University of Utah School of Medicine, Salt Lake City, Utah, USA.